InvestorsHub Logo
Followers 23
Posts 2679
Boards Moderated 0
Alias Born 08/25/2010

Re: None

Saturday, 08/22/2020 10:49:48 AM

Saturday, August 22, 2020 10:49:48 AM

Post# of 232945
Does anyone know when Brian Brothen came on board? Per his Linkedin it was July, I don't remember hearing or seeing anything.

Brian Brothen
Vice President of Global Oncology

Brian Brothen brings to CytoDyn over two decades of commercial pharmaceutical, diagnostic, and medical device oncology experience. He has excelled in sales, commercial leadership, business development, strategic planning, and key opinion leader development. Prior to joining CytoDyn, Mr. Brothen was the Vice President of Sales and Business Development for QT Ultrasound and Paradigm Dx, where he led the launch of the company’s new NGS cancer diagnostic test to help deliver personalized cancer therapy. Mr. Brothen has held numerous oncology sales and sales leadership positions at Agendia, Pharmion (Celgene), Sanofi, and Schering Plough. Mr. Brothen graduated from the University of South Florida with a degree in Business and Communications.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News